Photo of Mark Lewis from thepreventivemedicinepodcast.com
Sep 15, 2023, 18:04
Mark Lewis: For the moment I will NOT be using somatostatin receptor scintigraphy to routinely surveil my own or my practice’s MEN1 NETs.
Mark Lewis recently shared a post by Thorvardur (Thor) R. Halfdanarson on X/Twitter.
“I’m as cognizant of my own iatrogenic radiation exposure as I am of my patients’ — between EUS and MRI I’ve largely minimized it to date.
For the moment I will NOT be using somatostatin receptor scintigraphy to routinely surveil my own or my practice’s MEN1 NETs.”
Quoting Thor Halfdanarson’s post:
“To PET or not as a part of pNET surveillance in MEN1-related NETs. According to this study, using SSTR PET/CT, the additional information gained was limited and radiation exposure increased. It would be interesting to look at PET-MRI in this setting.”
For the article click here:
Source: Mark Lewis/Twitter and Thor Halfdanarson’s/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19